HPV Vaccination in India: Critical Appraisal | Zendy

Aruigam | Zendy; Pikee Saxena | Zendy; Anita Shankar Acharya | Zendy; Archana Mishra | Zendy; Swaraj Batra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HPV Vaccination in India: Critical Appraisal

Author(s) -

Aruigam,

Pikee Saxena,

Anita Shankar Acharya,

Archana Mishra,

Swaraj Batra

Publication year - 2014

Publication title -

isrn obstetrics and gynecology

Language(s) - English

Resource type - Journals

eISSN - 2090-4444

pISSN - 2090-4436

DOI - 10.1155/2014/394595

Subject(s) - cervical cancer , medicine , context (archaeology) , vaccination , panacea (medicine) , human papilloma virus , cervical carcinoma , developing country , cervical screening , carcinoma , cancer , gynecology , oncology , immunology , pathology , alternative medicine , biology , paleontology , ecology

Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research